id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-284008-vlwdtjbe	Li, Na	The Application of Corticosteroids in COVID-19: A Two-edged Sword	2020-06-25		.txt	text/plain	3092	189	48	Their study revealed that proper corticosteroid treatment resulted in lower mortality and shorter hospitalization stay in patients with critical SARS with an oxygenation index (OI) of <300 mm Hg, and it was not associated with significant secondary lower respiratory infection and other complications. [21] described the effect of different doses of adjuvant corticosteroid therapy on 30-or 60-day mortality of patients with influenza A (H1N1) pdm09 viral pneumonia through a retrospective analysis. The results of stratified analysis based on the doses of corticosteroids showed that only treatment with low-to moderate-dose corticosteroid could reduce 30-and 60-day mortality of patients with severe infection with PaO2/FiO2 <300 mm Hg. However, corticosteroids at any dose increased the 60-day mortality of patients with mild infection with PaO2/FiO2 >300 mm Hg. Cao et al. [25] reported the clinical characteristics and treatment of patients with COVID-19 with ARDS in a study available on the medRxiv preprint server.	./cache/cord-284008-vlwdtjbe.txt	./txt/cord-284008-vlwdtjbe.txt